IP Library › Assignment 022075/0734
Patent Assignment
Reel/Frame 022075/0734

Assignment of Assignor's Interest

Recorded: 2009-01-08 Pages: 12
Assignor
ADENOSINE THERAPEUTICS, LLC
Executed: 2008-08-20
Assignee
PGXHEALTH, LLC
ONE GATEWAY CENTER, SUITE 702, NEWTON, MASSACHUSETTS, 02458
Covered Properties (48)
Methods for Preparing 2-Alkynyladenosine Derivatives
Substituted 8-Heteroaryl Xanthines
Selective Antagonists of A2A Adenosine Receptors
Pyridyl Substituted Xanthines
Derivatives of 8-Substituted Xanthines
Pyrazolyl Substituted Xanthines
Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Substituted 8-[6-Amino-3-Pyridyl]Xanthines
Selective Antagonists of A2A Adenosine Receptors
Pyrrolo[3,2-D]Pyrimidines That Are Selective Antagonists of A2B Adenosine Receptors
Adenosine Derivative Formulations for Medical Imaging
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth in the Liver Following Resection
Methods for preparing 2-alkynyladenosine derivatives
Application: 10/848,403 →
Publication: US 2005/0033044
Substituted 8-Heteroaryl Xanthines
Patent: 7,342,006 →
Application: 10/923,592 →
Publication: US 2005/0065341
Selective Antagonists of A2A Adenosine Receptors
Patent: 7,217,702 →
Application: 11/097,251 →
Publication: US 2005/0282831
Pyridyl Substituted Xanthines
Patent: 7,601,723 →
Application: 11/362,387 →
Publication: US 2007/0072843
Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines
Patent: 7,598,379 →
Application: 11/362,390 →
Publication: US 2007/0105821
Derivatives of 8-Substituted Xanthines
Patent: 7,579,348 →
Application: 11/362,392 →
Publication: US 2007/0249598
Pyrazolyl Substituted Xanthines
Patent: 7,618,962 →
Application: 11/362,393 →
Publication: US 2007/0066631
Methods for the synthesis of substituted amino uracils
Application: 11/510,632 →
Publication: US 2007/0049757
Selective antagonists of A2A adenosine receptors
Application: 11/803,312 →
Publication: US 2007/0244134
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 7,589,076 →
Application: 11/804,165 →
Publication: US 2007/0270373
Substituted 8-[6-Amino-3-Pyridyl]Xanthines
Patent: 7,884,100 →
Application: 11/811,823 →
Publication: US 2008/0004292
Selective Antagonists of A2A Adenosine Receptors
Patent: 7,985,754 →
Application: 11/879,133 →
Publication: US 2009/0118309
Pyrrolo[3,2-D] Pyrimidines That Are Selective Antagonists of A2BADENOSINE Receptors
Patent: 7,470,697 →
Application: 11/897,678 →
Publication: US 2008/0125425
Substituted 8-Heteroaryl Xanthines
Patent: 7,732,455 →
Application: 11/956,876 →
Publication: US 2008/0200456
Methods for Preparing 2-Alkynyladenosine Deriviatives
Patent: 7,671,191 →
Application: 11/975,080 →
Publication: US 2008/0177055
Adenosine Derivative Formulations for Medical Imaging
Application: 12/014,949 →
Publication: US 2008/0219927
Selective Antagonists of A2A Adenosine Receptors
Application: 12/049,801 →
Publication: US 2008/0176858
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth in the Liver Following Resection
Application: 12/102,185 →
Publication: US 2008/0262001
Methods for preparing 2-alkynladenosine derivatives
Application: 60/471,643 →
Selective antagonists of A2A adenosine receptors
Application: 60/559,159 →
Derivatives of 8-substituted xanthines
Application: 60/656,086 →
Pyridyl substituted xanthines
Application: 60/656,087 →
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
Application: 60/656,104 →
Pyrazolyl substituted xanthines
Application: 60/656,105 →
Methods for the synthesis of substituted amino uracils
Application: 60/711,422 →
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Application: 60/747,625 →
Substituted 8-Heteroaryl Xanthines
Application: 60/805,030 →
Substituted 8-Heteroaryl Xanthines
Application: 60/805,564 →
Selective Antagonists of A2A Adenosine Receptors
Application: 60/807,545 →
Selective Antagonists of A2B Adenosine Receptors
Application: 60/824,316 →
Adenosine Derivative Formulations for Medical Imaging
Application: 60/885,489 →
Agonists of A2A adenosine receptors for treating recurrent tumor growth in the liver following resection
Application: 60/925,736 →
Substituted 8-[6-Amino-3-Pyridyl]Xanthines
Application: 61/014,134 →
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Application: 61/015,303 →
Intrathecal Treatment of Neuropathic Pain with A2AR Agonists
Application: 61/019,912 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 27, 2004
From: PICKERSGILL, IAIN F.; CHEESMAN, EDWARD H.
To: BRISTOL-MYERS SQUIBB PHARMA COMPANY
Reel/Frame 015089/0066 →
Assignment of Assignor's Interest Dec 3, 2004
From: WANG, GUOQUAN; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 015425/0229 →
Assignment of Assignor's Interest Sep 2, 2005
From: BEAUGLEHOLE, ANTHONY; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 016487/0660 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0129 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0139 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0496 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0328 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0204 →
Assignment of Assignor's Interest May 22, 2007
From: BRISTOL-MYERS SQUIBB PHARMA COMPANY
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019330/0287 →
Assignment of Assignor's Interest Jul 12, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019555/0937 →
Assignment of Assignor's Interest Mar 26, 2008
From: WANG, GUOQUAN; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020708/0784 →
Assignment of Assignor's Interest Mar 28, 2008
From: WANG, GUOQUAN; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020729/0289 →
Assignment of Assignor's Interest May 2, 2008
From: BEAUGLEHOLE, ANTHONY; SCHMIDTMANN, FRANK W.; RIEGER, JAYSON M.; WATKINS, LINDA
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020896/0198 →
Assignment of Assignor's Interest May 30, 2008
From: WANG, GUOQUAN; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 021031/0742 →
Assignment of Assignor's Interest Aug 12, 2008
From: BEAUGLEHOLE, ANTHONY; REIGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 021377/0599 →
Assignment of Assignor's Interest Nov 20, 2008
From: ADENOSINE THERAPEUTICS, LLC
To: PGXHEALTH, LLC
Reel/Frame 021867/0071 →
Assignment of Assignor's Interest Apr 20, 2009
From: KRANENBURG, ONNO; VAN DER BILT, JARMILA; RINKES, INNE BOREL; RIEGER, JAYSON M
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 022568/0395 →
Assignment of Assignor's Interest Apr 20, 2009
From: ADENOSINE THERAPEUTICS
To: PGXHEALTH, LLC
Reel/Frame 022568/0447 →
Change of Name Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025709/0994 →
Merger Jan 24, 2013
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 029688/0503 →
Merger Jan 25, 2013
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 029694/0831 →
Merger Jan 31, 2013
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 029728/0445 →
Merger Jan 31, 2013
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 029728/0400 →
Assignment of Assignor's Interest Feb 1, 2013
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 029736/0958 →
Assignment of Assignor's Interest Feb 1, 2013
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 029737/0389 →